Skip to main content
. 2020 Apr 28;26(16):1912–1925. doi: 10.3748/wjg.v26.i16.1912

Table 4.

Serum levels of pro and anti-inflammatory cytokines in inflammatory bowel disease and colorectal cancer patients

Cytokines IBD patients CRC patients P value (U-test)
TGFB1 (ng/mL) 11.19 (9.36-20.99) 22.57 (18.08-29.65) 0.0008
IL-10 (pg/mL) 0.4 (0.0-2.8) 8.29 (6.75-15.12) 0.000001
IL-6 (pg/mL) 0.0 (0.0-2.7) 3.21 (2.03-4.19) 0.012
IL-23A (pg/mL) 0.7 (0.0-3.7) 27.55 (25.35-33.0) 0.000001
IL-17A (pg/mL) 0.0 (0.0-0.26) 2.85 (0.0-9.0) 0.034

The results are presented as median (IQR: 25%-75% percentile). IBD: Inflammatory bowel disease; CRC: Colorectal cancer.